Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081652 | SCV000113583 | likely benign | not specified | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704004 | SCV000209422 | benign | not provided | 2020-02-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313791 | SCV000849199 | likely benign | Inborn genetic diseases | 2022-12-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000868034 | SCV001009319 | likely benign | Mowat-Wilson syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000868034 | SCV002045694 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001704004 | SCV004151263 | benign | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | ZEB2: BS1, BS2 |
Prevention |
RCV003925071 | SCV004745755 | likely benign | ZEB2-related disorder | 2022-05-25 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |